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Edited by Gianni CesareniAbstract Large amounts of reﬁned sequence material in the
form of predicted, curated and annotated genes and expressed se-
quences tags (ESTs) have recently been added to the NCBI dat-
abases. We matched the transcript-sequences of RefSeq,
Ensembl and dbEST in an attempt to provide an updated over-
view of how many unique human genes can be found. The results
indicate that there are about 25000 unique genes in the union of
RefSeq and Ensembl with 12–18% and 8–13% of the genes in
each set unique to the other set, respectively. About 20% of all
genes had splice variants. There are a considerable number of
ESTs (2200000) that do not match the identiﬁed genes and we
used an in-house pipeline to identify 22 novel genes from Gen-
scan predictions that have considerable EST coverage. The study
provides an insight into the current status of human gene cata-
logues and shows that considerable reﬁnement of methods and
datasets is needed to come to a conclusive gene count.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Databases; Genscan1. Introduction
One of the most intriguing questions in human biology is the
number and identity of the human genes. Three years after the
release of the genomic sequence [1,2], there are still large uncer-
tainties about the exact number of human genes. The number
of known and hypothetical genes in current databases such as
RefSeq and Ensembl is continuously growing but is still less
than the predicted number of genes [1–8], indicating that these
datasets are incomplete. Moreover, there are signiﬁcant diﬀer-
ences between these datasets. Identiﬁcation and annotation of
human genes is likely to continue to be an important issue
within the ﬁeld of genetic research in several years to come.
Historically, the highest estimates for the human gene count
have been based on clustering of expressed sequences tags
(ESTs) and many uncertainties with such methods have been
pointed out. Fields and colleagues used a method based on
similarity between known cDNA sequences and ESTs to calcu-
late an approximate number of human genes [3]. They esti-*Corresponding author. Fax: +46 18 51 15 40.
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clusters would represent about 50% of all genes, which from
their sim35000 clusters would correspond to about 60000–
70000 genes. Davidson and Burke [4] used a similar method
based on clustering human EST sequences into transcription
units to reach a number of about 70000 genes, with between
1.2 and 1.5 diﬀerent transcripts per gene. Both of these meth-
ods suﬀered from the fact that normalization of cDNA li-
braries may enrich for contaminants and aberrant clones.
The problem of genomic contamination has been estimated
to aﬀect 5–8% of all ESTs [9,10]. Moreover, the former method
included singleton clusters, which may also cause overestima-
tion of the total number of genes.
Another high number was reached by extrapolating from
correlation between human genes and genomic CpG islands.
It was estimated that half of the human genes were accompa-
nied by a neighboring region of above average CpG dinucleo-
tide content. The number of CpG islands was calculated to
around 40000, which led to an estimate of 80000 human genes
[5]. This early estimate assumed that each CpG-island corre-
sponds to a unique gene, while a later analysis of chromosome
22 showed that this is only true for about 60% of the islands.
The public sequencing project reported the existence of only
about 29000 islands in non-repeatmasked areas in the analysis
of the ﬁnished genomic sequence. With these data, the estimate
of this method would be lowered to about 35000 human genes,
a number not far from the currently popular quote derived
from both sequencing projects [1,2].
Predictions made by ab initio programs such as Genscan [11]
have proven to be rich source of novel genes. In 2001, the false
positive rate for Genscan was estimated on chromosome 22
using microarray analysis. This study concluded a false posi-
tive fraction of 17% compared to the original estimate by the
chromosome 22 sequencing group of 27.5% [12,13]. Using this
assumption and predicting that the rate is constant over
the other chromosomes, this would mean that 7368
(0.17 · 43000) genes from the whole Genscan set of 43000
genes are false predictions. The remaining set of about 35600
human predictions is signiﬁcantly larger than any known gene
set (RefSeq, Ensembl, SWISS-PROT, TrEMBL), of which the
Ensembl set is the largest, currently containing 29802 human
transcripts. Evidence of actual transcription of predicted genes
can be obtained by identifying mRNA and EST sequences
matching the predictions. The growth of dbEST from 2 million
sequences in 2001 to over 5 million today means that the like-
lihood of ﬁnding transcript evidence for novel predictions is
better than ever. Since 2002, the University of California Santa
Cruz (UCSC) has provided data on genomic alignments for allblished by Elsevier B.V. All rights reserved.
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ESTs with gene predictions based on genomic location rather
than sequence similarity. Cross matching ab initio predictions
such as Genscan predictions with ESTs remains thus as an
important method to verify gene predictions and identify
new genes.
Creation of a complete set of known and hypothetical genes
requires merging of existing datasets into a non-redundant set
of genes. Such merging is often based on a sequence similarity
threshold [14,15] that is prone to misjudgements, since it is dif-
ﬁcult to ﬁnd a threshold that always gives the correct result.
Another method of merging sets of transcripts is to align all se-
quences to the genome and determine which sequences from
each set that are not overlapped by any sequence form the
other set. However, for transcript-sequences that are not de-
ﬁned directly from the genomic sequence, it can be a problem
to ﬁnd good quality genomic alignments. For example, the
UCSC table refGene, which contains positions for RefSeq
transcripts as acquired by BLAT, only includes about 22000
of the 27000 transcripts in the set. The inability to ﬁnd good
quality alignments can be problematic when using this method.
Using genomic sequence to deﬁne transcript-sequences, as is
done by Ensembl, should alleviate this problem. The increased
quality of the genome sequences should also make this prob-
lem smaller. The continuous changes of the databases make
it a diﬃcult and time-consuming issue to practically ‘‘count’’
known unique genes in an unbiased fashion. Since the publica-
tion of the ﬁrst analysis of the human genome, the NCBI Ref-
Seq catalogue of human transcripts [16] has grown from just
above 11000 entries [1] to over 27000 [RefSeq release 4], while
the EMBL/Sanger Ensembl database [17] currently contains
around 29800 non-pseudogene transcripts. The level of syn-
chronization of these two datasets is an indicator of the reli-
ability of the methods to produce the catalogues and the
merging of these two provides a lower bound for the number
of known human genes. In 2001, the overlap between the hu-
man RefSeq and Ensembl gene sets was analyzed and the per-
centage of genes unique to each set was estimated to be 10%
and 53%, respectively [14]. One year later, the ratios were
found to be 8% and 37% [15]. Since these most recent compar-
isons, more than 10000 new RefSeq transcript-sequences have
been added. Moreover, the quality of the genome assemblies is
continually increasing. From June 2002 to November 2003, the
number of bases considered to be of ﬁnished quality in the hu-
man assembly rose from 0.78 to 2.8 billion and the number of
contigs of ﬁnished quality simultaneously decreased from 509
to 388. Based on these facts, it is important to continuously
determine if the merging of these two gene sets leads to a lower
number/percentage of unique genes in each set.
In this work, we have analyzed the content of the NCBI hu-
man RefSeq and human Ensembl gene sets with respect to
duplicates (not actual duplicated genes, but redundant tran-
script-sequences with more than one name), the number of
genes, alternative splice variants, and the amount of unique
transcript-sequences in each set. The purpose of this was to
present an updated overview of these two sets and to see if
the number of sequences unique to each set has continued to
decrease. This analysis shows that there is a considerable
redundancy in both sets, that there are still a high number of
unique genes in each of these sets, and that at least 20% of
the human genes in these sets have alternative splice variants
in the databases. We also show that it is still possible to ﬁndnovel genes from the Genscan set and we present 22 novel
genes with extensive EST support identiﬁed by ﬁltering Gen-
scan predictions through a special in-house pipeline.2. Materials and methods
2.1. Datasources
2.1.1. NCBI. The 2004-04-05 version of the RefSeq nucleotide
transcript-sequences of Homo sapiens was downloaded from NCBI
(ftp://ftp.ncbi.nih.gov/RefSeq/) as ﬁles in FASTA format.
Time of download was used as an identiﬁer due to the continuous
update of the RefSeq dataset. For simplicity, instead of sorting Ref-
Seq transcripts according to all six oﬃcial categories: Model, Inferred,
Predicted, Provisional, Validated and Reviewed, transcripts with
name preﬁxes N (NM,NR) and X (XM/XR) were deﬁned as reviewed
and predicted, respectively. At the time of download, this ﬁle con-
tained 27602 sequences. The human ESTs were downloaded as a
FASTA ﬁle from NCBI (ftp://ftp.ncbi.nih.gov/blast/db/FASTA/
est_human.gz). At the time of download, the ﬁle contained 5484645
ESTs.
2.1.2. Ensembl. The 2004-04-05 Ensembl human transcript set
based on the NCBI genome assembly 34 was downloaded in cDNA
FASTA format from (ftp://ftp.ensembl.org/pub). The Ensembl tran-
scripts fall into three categories: known, novel and pseudogene, and
in each comparison with RefSeq, we let known correspond to re-
viewed and novel to predicted. When referred to as Ensembl genes
or Ensembl transcripts, only sequences of statuses known and novel
are intended unless otherwise speciﬁed. At the time of download, this
ﬁle contained 31609 sequences divided into 26309, 3493 and 1807
known, novel and pseudogenes, respectively. The ESTgene dataset
version 25.34 for the NCBI34 assembly was downloaded using the
EnsMart retrieval system. At the time of download, this set consisted
of 24980 sequences.
2.1.3. UCSC. The human genome assembly based on NCBI 34
was downloaded as unmasked FASTA ﬁles from (ftp://hgdown-
load.cse.ucsc.edu/goldenPath/hg16/). The tracks (see below) for human
ESTs, the human Genscan predictions, the knownGene transcripts and
the AceView [18] transcripts were downloaded as SQL tabular data
ﬁles and imported into a local database. A UCSC track is a table of
the positions on a genome for a set of nucleotide or protein sequences
produced by aligning their sequences to the genome with BLAT. The
exact criteria used to include alignments into these tracks are stated
at http://genome.ucsc.edu/goldenPath/help/hgTracksHelp.html.
2.1.4. Gene Ontology. The MySQL dump of the Gene Ontology
database was downloaded from (http://www.godatabase.org/dev/data-
base/archive/2004-03-01/). From this database, the protein-sequences
that have been assigned gene products were extracted and formatted
into a BLAST database.
2.1.5. PIR. The Protein Information Resource (PIR) located at
Georgetown University Medical Center maintains PIR NREF, a data-
base of all known proteins from PIR-PSD, SwissProt, TrEMBL, Ref-
Seq, GenPept, and PDB. The PIR NREF database, release 1.47, was
downloaded from (ftp.pir.georgetown.edu/pir_databases/) as a FAS-
TA ﬁle. This ﬁle contained 1634871 sequences.2.2. RefSeq/Ensembl sequence comparison
The RefSeq and Ensembl transcript sets were compared at nucleo-
tide level using MegaBlast [19]. A BLAST database was created from
each FASTA ﬁle. The sequences from the other FASTA ﬁle were
aligned to the sequences in the database with MegaBlast (wordsize
16) and keeping only alignments with an E-value of 1e  3 or smaller.
For a transcript-sequence to be classiﬁed as existing in the other data-
base, an alignment of at least 100 bases with at least 98% identity was
demanded.2.3. Alternative transcript/redundancy analysis
Tables of chromosomal locations for all RefSeq and Ensembl tran-
script-sequences were created by aligning them to the UCSC genome
with BLAT using standard parameter settings. For each sequence, only
the best hits (highest value of matches) were kept and furthermore,
only alignments with greater than or equal to 95% matches were used.
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retained and we considered such sequences separately as described be-
low. Similar table exists at UCSC but to include as many sequences as
possible we produced our own. Compared to the UCSC tables for
which a criterion of 98% identity is used, our RefSeq table thus in-
cluded 26700 transcripts compared to their 22000. For each sequence,
its alignment was compared with those of all other sequences. If an-
other sequence could be found with exactly the same transcript start
and end positions, the same number of exons and exactly the same
positions for all splice sites, it was classiﬁed as a redundant candidate.
From the set of redundant candidates, all sequences with more than
one alignment were removed as they could be true duplicates. All
remaining redundant candidates were compared on a sequence to se-
quence level and only those sequence pairs with exactly the same nucle-
otide sequence were classiﬁed as redundant. If these criteria were not
fulﬁlled, but the sequences were found to be overlapping on the gen-
ome, they were classiﬁed as alternative splice variants. Each disjoint
group of transcripts with mutually overlapping genomic positions
was deﬁned as a gene. The number of genes from a given set of se-
quences was calculated as follows. For each chromosome, a list of
all sequence alignments was created and sorted in order of increasing
start base. This list was iterated over and each time an alignment
was encountered whose end coordinates did not overlap the former se-
quence, a new gene entry was created. As the iteration continued, if a
sequences start base was less than the genes end base, the genes end
base was extended to include this sequence alignment.2.4. RefSeq EST coverage
The human ESTs were formatted into a BLAST database. The hu-
man RefSeq and Ensembl transcripts-sequences were aligned to the
EST-sequences in the database using MegaBlast with wordsize 16
and E-value 1e  5. For each query sequence, the number of EST
alignments with length >60 bases and identity >95% was counted.
The number of human ESTs with genomic alignments outside align-
ments of known human genes was retrieved from a crossmatch be-
tween the UCSC precomputed EST alignment data all_est and the
union of the UCSC table knownGene with the genomic alignments
of all human RefSeq and Ensembl sequences we produced as described
above. The same method was used to retain the set of AceView tran-
scripts outside known genes. AceView oﬀers an integrated view of
the human and nematode genes as reconstructed by alignment of all
publicly available mRNAs and ESTs on the genome sequence. Ace-
View transcripts are not predictions, just careful alignment and cluster-
ing of experimental cDNA data.2.5. Finding novel genes in the Genscan set
Positional data on the Genscan-predicted human genes, the known-
Gene gene set, and the set of all human ESTs were downloaded from
UCSC in SQL tabular form. Similar tables of gene positions were cre-
ated locally for the human RefSeq and the human Ensembl tran-
script-sets by aligning these sequences on the UCSC genome with
BLAT. From the total Genscan set, the subset of predictions without
any overlapping sequences from either of the above mentioned sets
was selected. This set consisted of 13178 predicted genes. This set
was further reﬁned, by comparing the positions of these predictions
with the human EST alignments. All Genscan genes with either all
their exons, or at least four exons partially covered by an EST were
selected for further inspection. From these 293 predicted genes, the
50 with the highest total number of overlapping ESTs were analyzed
manually. To further ensure that the ESTs that had been regarded as
supporting evidence for the predicted gene actually represented that
gene and had not been placed incorrectly by BLAT, all overlapping
ESTs from these 50 predictions were compared to a database of both
the 50 Genscan predictions and all proteins from PIR NREF. Only
the ESTs for which the highest scoring match was against the Gen-
scan gene which it overlapped was counted. This class of ESTs were
named conﬁrmed ESTs. The novelty of the remaining predictions was
further validated by aligning the Genscan predictions against PIR
NREF using BLASTX. Genscan sequences apparently identical (iden-
tity >99% over the alignment) to a sequence from the PIR-NREF
dataset were removed. When the identity of the alignment was be-
tween 90% and 99%, the matching PIR-NREF sequence was posi-
tioned on the genome using the UCSC web BLAT service together
with the original Genscan prediction and only if the best alignmentsfor these sequences did not overlap, the prediction was kept as novel.
When the quality of the alignment was of worst quality, but still good
enough for suspecting this to be the same gene, the matching protein
was positioned on the genome using the UCSC web BLAT service to-
gether with the original Genscan prediction and only if the best align-
ments for these sequences did not overlap, the prediction was kept as
novel. This ﬁnal set of novel Genscan predictions consisted of 22
genes.3. Classiﬁcation of transcript function
3.1. Gene Ontology description
The Gene Ontology consortium provides a database of pep-
tide-sequences coupled to three diﬀerent hierarchical trees
(molecular function, biological process, and cellular compo-
nent). For each of the sequences in the database, a link to at
least one description from of each of these trees exists. The
hierarchical structure of each tree is organized such that the
most speciﬁc descriptions are at the leaves of the tree, with
more general descriptions at nodes closer to the root of the
tree. For example, one could follow the classiﬁcation of GO
term GO:0018479 from its leaf (benzaldehyde dehydrogenase
(NAD) activity) to root (catalytic activity) in the molecular
function tree.
3.2. Classiﬁcation strategy
The GO sequences were extracted from the database into a
FASTA ﬁle and formatted into a BLAST database. All the se-
quences to be classiﬁed were compared with the database using
BLASTP and an E-value of 1e  3. Each sequence was as-
signed the same GO category as the category of the best
matching GO sequence. Sequences with no signiﬁcant matches
were grouped into a category called unmatched.4. Results
4.1. Redundancy and alternative transcripts
We evaluated the number of duplicated (redundant, occur-
ring more than once in the dataset) sequences, alternative
transcripts (transcripts belonging to a gene with alternative
splice variants) and the number of genes in the human Ref-
Seq and Ensembl transcript-sets by examining the positions
of the sequences as they were aligned to the UCSC Golden-
Path genome with BLAT [20]. An alternative transcript se-
quence was deﬁned as a sequence with positional overlap
with any other non-identical sequences. The position was in-
ferred from genomic alignments and we considered only
alignments with 95% identity and only the best alignments
for each sequence were kept. Positional overlap was deﬁned
as alignments from the same strand and sharing at least
one base. From the genomic alignments, any group of se-
quences with a non-broken stretch of overlapping alignments
were deﬁned as a gene (Section 2).
Fig. 1a and b shows the results from the analysis. Of the
27606 RefSeq transcript-sequences, 26723 (97%) could be
aligned to the UCSC GoldenPath assembly and our method
suggested 443 redundant sequences, 2972 (13.5%) genes with
alternative splice variants from a total of 22007 genes. The to-
tal number of transcripts for the 2972 genes with alternative
splicing was 7285, resulting in an 1.21 and 2.45 transcripts
per gene in average for the whole set and the set of alterna-
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Fig. 1. (a) A comparison for Homo sapiens of the number of known (light), novel (medium) and pseudogene (dark) transcripts of Ensembl to the
number of reviewed (light) and predicted (medium) of RefSeq. (b) Bar graphs comparing total number of human transcripts, duplicate sequences,
genes with alternative splice variants and total gene count between Ensembl (darker) and RefSeq (lighter). (c, d) The distribution of transcripts
unique to each of the two sets according to our second method. (c) shows that 4464 RefSeq sequences (705 NM/NR, 3759 XM/XR) are absent in
Ensembl and (d) shows that 4918 Ensembl sequences (3453 known, 1465 novel) are absent in RefSeq. The Ensembl pie chart represents all sequences
with status known or novel. (e) The distribution of RefSeq sequences as a function of the number of matching human ESTs. Only 6% of all sequences
did not match an EST.
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human Ensembl transcript-sequences, 29489 (99%) could be
aligned to the genome assembly. Our method suggested 15
redundant sequences, 5434 (25%) genes with alternative splice
variants from a total of 21429 genes. The total number of tran-
scripts for the 5434 genes with alternative splicing was 13575,
resulting in an 1.39 and 2.50 transcripts per gene in average for
the whole set and the set of alternatively spliced genes, respec-
tively, identiﬁed with having more than two splice variants.
The 443 duplicate RefSeq sequences were grouped into 221
groups. Similarly, the 15 Ensembl duplicates originated from
seven groups. All the sequences that were found to be dupli-
cates and alternative transcripts can be obtained at http://
www.neuro.uu.se/medfarm/schioth.html.
A total of 262 RefSeq transcript-sequences aligning to sev-
eral disjoint locations were found. For a subset of 164 se-
quences, these multiple alignments were perfect (100%
identity) matches against the genome, suggesting that these
are true duplicated genes.4.2. Unique sequences in RefSeq and Ensembl
In order to measure the number of unique and common se-
quences between the human gene sets of RefSeq and En-
sembl, we performed two separate comparisons. At ﬁrst, an
‘‘all against all’’ alignment search similar to the ones done
in earlier studies [8,24] was performed between the two sets
of transcript-sequences using BLAST [21]. A sequence was re-
garded as existing in the other set, if a nucleotide alignment
could be found between the two that were greater than or
equal to 100 bp in length, with identity greater than or equal
to 98% over the alignment. A consequence of these permis-
sive criteria is that two sequences that share just a single
small exon will be classiﬁed as common to both sets, and also
that if one splice variant of a gene is present in one set, all
splice variants of the gene that are present in the other set
and contain the same exon are classed as common. More-
over, recent duplicated genes that have not diverged beyond
the 98% identity limit will also be classiﬁed as common.
The consequence of this method is that the number of unique
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mated than overestimated.
The second comparison between the two sets was made
based on genome location. For each sequence, a genomic posi-
tion was deﬁned by the best BLAT alignment of the sequence
to the UCSC GoldenPath genome assembly. Where the posi-
tions of two sequences, one from each set, were found to be
overlapping by at least one nucleotide, they were considered
common.
In order to estimate how many unique genes these sequences
represented, the unique transcripts were clustered into groups
according to their genomic positions in the same way as de-
scribed above. Fig. 1c and d shows these results. By the ﬁrst
method, we found that 3121 RefSeq transcripts (2861 genes)
were not represented in the Ensembl set and 2123 Ensembl
transcripts (1615 genes) were not included in RefSeq. The cor-
responding numbers from the second method were 4464 un-
ique RefSeq transcripts (4103 genes) and 4918 unique
Ensembl transcripts (2695 genes).
The total number of unique human genes in the union of
RefSeq and Ensembl was calculated as the sum of the number
of genes from one set and the number of genes unique to the
other set. Thus, an upper bound on the number of genes in
these two sets was 25532 genes (21429 Ensembl genes plus
4103 unique RefSeq genes) and a lower bound was 23622
(22007 RefSeq genes plus 1615 unique Ensembl genes).Fig. 2. Flowchart for our method for novel gene discovery. A set of
known gene genomic coordinates are created by combining UCSC
precompiled knownGene data with BLAT genomic alignments of
RefSeq and Ensembl sequences. All Genscan genes (positions from
UCSC) with any overlapping known gene are ﬁrst removed from
consideration. Next, using EST-genomic alignments all genes without
either all or at least four exons covered by an EST are removed.
Remaining sequences are classiﬁed with Gene Ontology. A subset of
the 50 predictions with most novel EST coverage is specially analyzed.
A ﬁnal check for novelty is done by ﬁnding all similar proteins in the
PIR-NREF database, and by repositioning all signiﬁcant hits on the
genome, discarding any predictions with overlapping known se-
quences. Finally, all ESTs found to overlap the novel genes are
compared against the union of PIR-NREF with the novels and only
ESTs that match the novel gene better than any sequence from PIR-
NREF are kept.4.3. Evaluation of EST coverage over human sequences
Conﬁrming novel genes from statistically predicted gene sets
may include the procedure of identifying ESTs or complete
mRNAs that can support actual transcription for that se-
quence. To estimate how eﬀective the current EST data are
for identifying genes, the number of RefSeq transcript-
sequences with EST coverage was calculated as follows. Each
RefSeq transcript was matched against a BLAST database
built from all human ESTs. For each transcript, the number
of ESTs with suﬃciently good alignments was counted. Fig.
1e shows the results. Of the 27606 transcripts, 25987 (94%)
had at least one EST hit that could be aligned so that the align-
ment passed our criteria. Of the 1615 genes that could not ﬁnd
any EST alignments, 1290 were of status predicted and 325
were of status reviewed. There is a large diﬀerence between se-
quences with less curation, having signiﬁcantly fewer EST
alignments in general, and those that passed more curation,
which have many more EST alignments.
We used genomic alignments of the human ESTs from
dbEST to ﬁnd the number of ESTs outside known genes. By
removing any ESTs that overlapped a transcript from either
RefSeq or Ensembl, we found 2200000 remaining ESTs
(40% of all human ESTs). In a similar way, we counted the
number of novel EST based transcripts produced by the Ace-
View program and found 75851 novel transcripts from 61809
genes. The average number of exons in this set was 1.71 (as
compared with 10.4 in RefSeq), the average length from tran-
script start to transcript end was 8222 bases (56000) and the
average coding sequence was 156 (499) amino acids.4.4. Mining the Genscan set for novel genes
The human Genscan set, with about 44000 predictions, was
mined for possible novel genes by a method that conﬁrmed
EST evidence for each gene and simultaneously discardedany genes already present in databases of known human
genes (see Section 2). Fig. 2 shows an overview over this
method. First, a set of known sequence locations were created
from the union of the UCSC precomputed data on known
gene locations and our determined positions of RefSeq and
Ensembl genes, and all Genscan predictions that overlapped
a sequence from this set were removed. Then, in the same
way, precomputed EST locations from UCSC were used to
remove the Genscan predictions with no overlapping ESTs.
As a preliminary novel gene set, the 294 Genscan predictions
for which either all exons or at least four exons had EST cov-
erage were chosen. This data set can be obtained at http://
www.neuro.uu.se/medfarm/schioth.html. In an intermediate
step, this set was classiﬁed with the Gene Ontology (GO) sys-
tem in categories according to probable molecular function,
cellular component and biological process [22]. A novel gene
was put into the same category as the most similar GO se-
quence and genes with no similar sequences were classed as
of unknown function. Fig. 3 shows the result from this
classiﬁcation.
(a)
(b)
(c)
Fig. 3. Pie charts showing the distribution of assigned (a) molecular function, (b) biological process and (c) cellular component for the novel genes.
Sequences were given a speciﬁc class based on similarity to sequences from the Gene Ontology database. A BlastP E-value of 1e  3 or better was
required to assign a category to a particular sequence. The major part of the unknown function sequences did not match any GO sequence and the
rest is due to the absence of an assigned function for the matching GO sequence.
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most overlapping ESTs were selected, and examined to fur-
ther conﬁrm their novelty and EST evidence. A second nov-
elty control was done in a similar way as before, using the
more comprehensive database PIR-NREF [23] as well as
the Ensembl ESTGenes. Since these databases also contain
many hypothetical genes from various sources, a further 28
genes were removed on the basis of existing overlapping se-
quences. For the remaining genes, a set of conﬁrmed ESTs
were determined by choosing only those ESTs that matched
our novels better than any human sequence from PIR-
NREF. Table 1 shows a summary of the 22 novel genes, with
their number of conﬁrmed ESTs, and most similar PIR-NREF protein. These sequences can be obtained from our
webpage (see above).
During the submission process, seven of these novels ap-
peared as hypotethical genes from other sources, four of them
identiﬁed in PIR, and three from the Ensembl ESTgenes (see
Table 2).5. Discussion
Since the last comparison between the human RefSeq and
Ensembl transcript sets [14,15], the number of human se-
quences in RefSeq has almost doubled. We investigated if
Table 1
Identiﬁer, the number of ESTs and a suggested function for each of the
22 novel genes
Identiﬁer ESTs Speculated function
NT_004668.122 89 Unknown
NT_005403.894 15 Unknown
NT_007933.1185 3 Ribosomal protein
NT_010194.560 5 Replicative senescence downregulated
leo1-like protein
NT_010783.119 6 Mitochondrial ribosomal protein
NT_010799.221 18 TAF5L protein
NT_010879.73 31 HSBP1-like protein (Fragment)
NT_011520.246 7 Beta crystalline B2 (BP) [Homo sapiens]
NT_011520.51 18 Hypothetical protein XP_209394
[Homo sapiens]
NT_011520.650 27 Neuroﬁlament protein
NT_021877.24 23 Unknown
NT_022517.622 13 Unknown
NT_023089.443 20 Unknown
NT_023666.177 28 Splicing coactivator subunit
NT_023935.75 6 Heat-shock protein
NT_024524.805 7 Unknown
NT_025741.357 126 Unknown
NT_026437.1709 5 Unknown
NT_029419.505 2 Unknown
NT_035036.5 3 Mitochondrial import inner membrane
translocase subunit
NT_077569.200 32 Seroreactive antigen BMN1-2 precursor
NT_079533.4 16 Unknown
The suggested function is based on a combination of domain hits
against NCBIs conserved domain database and the function of similar
known proteins from PIR-NREF.
Table 2
In-house identiﬁers and corresponding PIR and ESTGenes identiﬁers
for the seven predictions that during the submission process were
found as existing hypothetical genes
Identiﬁer Corresponding PIR/ESTgenes identiﬁer
NT_011520.512 NF00829103
NT_025741.357 NF01920147
NT_035036.5 NF00108853
NT_079533.4 NF01917990
NT_010879.73 ENSESTT00000035942.0
NT_011520.246 ENSESTT00000031372.0
NT_011520.650 ENSESTT00000036044.0
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gene sets still prevails. From 2001 to 2002, the part of human
RefSeq sequences not present in the Ensembl set was reduced
from 10% to 8% (1111, 1053 sequences) and the part of En-
sembl sequences not present in the RefSeq set from 53% to
37%. We found by using our two diﬀerent approaches that
3121 or 4464 human RefSeq transcripts (11% or 16%) do not
exist in the human Ensembl set and that 2123 or 4918 tran-
scripts from Ensembl do not exist in RefSeq (7% or 16%). It
is thus evident that the recent increase in these databases has
not resulted in percentage increase in the number of common
genes. It is interesting to note that large part of the unique Ref-
Seq sequences (84–87%) has only passed a minimum of cura-
tion (XM/XR sequences), which could explain the increase in
unique sequences, since the large increase in the number of
RefSeq sequences is mostly due to the addition of low curation
status sequences. The RefSeq sequences of lowest status of
curation (Model) are derived from predictions of the program
Genomescan, while the Ensembl pipeline uses a combinationof the programs Genewise [24] and Exonerate [25]. Since no
gene prediction programs to date predict the exact same gene
set, it is perhaps not surprising that an increase in the number
of Model sequences is accompanied by an increase in unique
sequences. It seems likely that the inconsistencies of the gene
predictions programmes are causing important discrepancies
in the databases. Another source of the diﬀerences could be
the diﬀering criteria for transcription evidence for predicted
genes.
The union of current human RefSeq and Ensembl gene sets
contains about 25000 unique genes with a mean of 1.3 splice
variants per gene. This is a similar number as the predictions
(guesses) made by Rowen and Jaillon of 25947 and 27462,
respectively, to which European Bioinformatic Institute
awarded the Genesweep prize in 2003 [26]. The percentage of
genes with alternative splice variants was estimated to be
14% and 26% for RefSeq and Ensembl genes, respectively,
which is why the Ensembl set is slightly larger than the RefSeq
set. This is lower than the 35–59% that has been estimated in
other works [1,27,28]. One reason for this diﬀerence could be
that the methods in these analyses used either mainly EST data
or genes from only chromosome 22. However, neither RefSeq
nor Ensembl use ESTs as an exclusive source of gene predic-
tion and have not focused on providing splice variants, while
other datasets such as the Ensembl ESTgene set focus on splice
variants [29]. The amount of splice variants is a function of the
level of annotation and analyses of the genes from the chromo-
some 22 that have been studied in detail may have resulted in
more accurate numbers.
It is important for the evaluation of the numbers in the dat-
abases to determine the quality of the redundancy within each
data set. Recently duplicated genes may be very similar and it
may be diﬃcult to distinguish them from redundant sequences
based only on the level of similarity. As the accuracy of the
genomic assemblies has improved considerably, this has en-
abled the more speciﬁc method of genomic alignments to dis-
criminate between possible duplicates and real redundancies.
We examined both sets for redundant sequences by identifying
sequences with the exact same nucleotide sequence and found
443 and 15 such redundancies in RefSeq and Ensembl, respec-
tively. These results are surprising, since especially RefSeq
states its non-redundancy ideal. RefSeq speciﬁcally aims to
contain a non-redundant representation of all existing DNA,
RNA and protein molecules. We have not found any explana-
tion to these redundancies but the analyses show that the
redundancy levels should be considered when comparing these
data sets.
If the recently popular quote of about 30000 human genes
is correct, it seems that a large number of genes are still not
represented in either of the RefSeq and Ensembl datasets. If
these genes exist, they probably diﬀer in characteristics from
the known genes that current gene ﬁnding programs can de-
tect. It is perhaps possible to ﬁnd these elusive sequences by
reconﬁguring existing programs using new learning sets con-
sisting only of sequences that were missed earlier. Another
possibility is that a large portion of predictions made by pro-
grams such as Genscan, that have not been included in cur-
rent gene catalogues due to lacking transcript evidence,
nevertheless are true genes, as was observed on chromosome
22 [30].
The rapid growth of EST data during the last years has in-
creased the possibility to verify transcription of computationally
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mate the amount of RefSeq sequences that could ﬁnd support
from ESTs. Our results indicate that 94% of the human RefSeq
transcripts have EST support. We wanted to examine if any
novel genes could be found in the set of Genscan predictions
that have good EST support. We cross-compared genomic
alignments of human ESTs with Genscan predictions and
found 2406 novel predictions covered by at least one EST.
By increasing the requirement to 2, 3, 4, 5 and >5 ESTs, the
numbers dropped to 1293, 893, 602, 460, 377, respectively.
We have provided these sequences as supplementary data as
they may be a good source for identifying new genes. We se-
lected 50 of these sequences from a subset of novel predictions
for which either all exons or at least four exons were partially
covered by ESTs and did a thorough analysis of their novelty
and transcript evidence. 22 such novel predictions remained
with an average coverage of 23 ESTs. This approach indicates
that there are good opportunities to discover additional new
genes that are not found in the current databases in similar
way as we have recently identiﬁed several new G-protein cou-
pled receptors [31–33]. It is diﬃcult to know exactly why these
genes have not previously been identiﬁed, but this could prob-
ably be related to the usage of diﬀerent gene ﬁnding programs
to generate ab initio sets as well as the diﬀerent thresholds used
for identifying EST evidence for the predicted genes. During
the submission process, seven of our novel genes have ap-
peared in existing databases as hypothetical genes from other
sources, a fact which strengthens our belief in the validity of
these predictions. For example, three genes match genes from
the Ensembl ESTGene set which is a purely ESTdriven pro-
gram. Since our method also relies heavily on EST coverage
for our predictions, we are curious about the reason why not
all our predictions could be found in the ESTGene set. A pos-
sible explanation could be that the number of EST alignments
used as input to the ESTGene algorithm (2.7 million) is far less
than the number of alignments used in this paper (5 million).
The optimal criterion for which ESTs are to be included in
similar methods has not been estimated to our knownledge,
but such information would surely be appreciated. Another
reason could be that even if an optimal criterion is found, there
might be ESTs which then are dismissed but which in cooper-
ation with an ab initio program, such as Genscan, would yield
correct predictions.
We assigned functional categories to the above mentioned
novel predictions and to the RefSeq dataset using the Gene
Ontology system. About 40% of the sequences in both sets
could be assigned a function. The part with no function as-
signed was due to either the absence of a similar GO sequence
or due to unknown function of the matching sequence. Se-
quences in RefSeq were evenly distributed between these cate-
gories, while all the novel predictions were of the ﬁrst type. It is
indeed likely that the genes that are yet to be identiﬁed are rel-
atively more diﬀerent from those we know, but the fact that the
new genes we present have similar rate of assignment as the
RefSeq genes provides further support to the suggestion that
these are true genes.
EST based estimates of the number of human genes are
generally much higher than estimates by other methods
(see Section 1). We used genomic alignments of human
ESTs and found that more than 2200000 ESTs lie outside
the known gene regions (RefSeq and Ensembl). This is
about 40% of the human ESTs in dbEST. In a separateanalysis, we identiﬁed all predictions produced by the EST
driven program AceView that did not match the RefSeq
and Ensembl sets. The total number of predictions from
the 5 million ESTs was 220000 transcripts and we found
that 75000 transcripts from 61000 ‘‘genes’’ did not match
either RefSeq or Ensembl. The genomic lengths, number
of exons, and coding sequence lengths of the non-RefSeq
and -Ensembl matching predictions from AceView are all
much lower than the RefSeq average, a fact that may ques-
tion the validity of these sequences as full length genes. If it
would be assumed that these unidentiﬁed genes have the
same distribution of number of exons and that each of these
transcripts in average represents 1/5 of a gene (see Section
4), these transcripts would add another 9000 genes to the
human gene count, although admittedly this is a very rough
ﬁgure.
In conclusion, we have matched the sequences of RefSeq,
Ensembl and dbEST in any attempt to provide an updated
overview of how many unique genes can be found. The re-
sults indicate that there are about 25000 unique genes in
the union of RefSeq and Ensembl with 12–18% and 8–13%
of the genes in each set unique to the other set, respectively.
There is considerable amount of EST that does not match the
identiﬁed genes and it seems likely that there are many genes
that are likely to be found from this source. The position on
the chromosomes with both hits from the gene prediction
programmes and the ESTs is still likely to be a valuable
source to ﬁnd new genes. It is evident that considerable
reﬁnement of the databases and the methods used to produce
them are needed to come to a conclusive gene count for the
human genome.References
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